LAG-3 is overexpressed in many tumors, including melanoma, gastric, ovarian, anal and colorectal, hepatocellular, prostate, follicular, breast, head and neck, NSCLC, renal, pancreatic, and mesothelioma cancer [281] (Figure 1). Here, LAG3 is linked to melanoma.